| 标题 |
Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation
在无肿瘤BRCA1/BRCA2突变的新诊断晚期卵巢癌患者中，度伐单抗联合紫杉醇/卡铂联合贝伐单抗联合贝伐单抗联合奥拉帕尼维持治疗
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Philipp Harter, et al.Durvalumab plus paclitaxel/carboplatin plus bevacizumab followed by durvalumab, bevacizumab plus olaparib maintenance among patients with newly-diagnosed advanced ovarian cancer without a tumor BRCA1/BRCA2 mutation from DUO-O/ENGOT-OV46/GOG-3025.2024 SGO. |
| 求助人 | |
| 下载 | 暂无链接，等待应助者上传 |
围城
HEIKU
寻道图强
乐乐乐乐乐乐
坚强的广山
美好乐松
从容芮
愉快的真
想打就打007
cr_joker
甜甜穆
科研文献搬运工
Mutsu
乐乐
不配.
mmyhn
共享精神
自由的秋灵
Singularity
充电宝
Magali
皖公网安备34019202002308
